2.8(top 20%)
impact factor
9.2K(top 2%)
papers
198.5K(top 2%)
citations
128(top 5%)
h-index
2.9(top 20%)
impact factor
10.6K
all documents
211.7K
doc citations
185(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Genetic and clinical aspects of Charcot‐Marie‐Tooth's diseaseClinical Genetics1974750
2A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics2004738
3Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsClinical Genetics2009672
4Gene/environment causes of cleft lip and/or palateClinical Genetics2002609
5The molecular regulation of myogenesisClinical Genetics2000599
6Niemann-Pick disease type CClinical Genetics2003558
7A cytogenetic survey of 14,069 newborn infantsClinical Genetics1975484
8The Cowden syndrome: a clinical and genetic study in 21 patientsClinical Genetics1986478
9Genes and mutations causing retinitis pigmentosaClinical Genetics2013471
10Consanguinity and its relevance to clinical geneticsClinical Genetics2001427
11Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populationsClinical Genetics2007404
12The modular nature of genetic diseasesClinical Genetics2006371
13Epigenetic modifications in cancerClinical Genetics2012369
14Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP‐met30)Clinical Genetics1991350
15The changing survival profile of people with Down's syndrome: implications for genetic counsellingClinical Genetics2002339
16The contribution of H LA to rheumatoid arthritisClinical Genetics1989325
17Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in careClinical Genetics2016323
18Single nucleotide polymorphisms and the future of genetic epidemiologyClinical Genetics2000316
19Polymorphism of apolipoprotein EClinical Genetics1979316
20The Ehlers–Danlos syndrome, a disorder with many facesClinical Genetics2012310
21To tell or not to tell: barriers and facilitators in family communication about genetic riskClinical Genetics2003309
22Clinical features and natural history of Beckwith‐Wiedemann syndrome: presentation of 74 new casesClinical Genetics1994303
23X‐chromosome inactivation in female patients with Fabry diseaseClinical Genetics2016290
24Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart diseaseClinical Genetics1974283
25Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutationsClinical Genetics2009280
26The Human Phenotype OntologyClinical Genetics2010267
27Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnairesClinical Genetics1989265
28The McCune‐Albright syndrome: a lethal gene surviving by mosaicismClinical Genetics1986264
29Nature and nurture: the complex genetics of myopia and refractive errorClinical Genetics2011253
30Ascertainment in the sequential sampling of pedigreesClinical Genetics1977229
31The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapyClinical Genetics2004228
32Genetics of population isolatesClinical Genetics2002227
33Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemiaClinical Genetics2004227
34Polymorphism at the Apoprotein-E locus in relation to risk of coronary diseaseClinical Genetics2008227
35Predicting zygosity in Norwegian twin pairs born 1915-1960Clinical Genetics1983227
36Spinocerebellar ataxia: relationship between phenotype and genotype – a reviewClinical Genetics2016226
37PALB2 mutations in European familial pancreatic cancer familiesClinical Genetics2010223
38Primary care physicians' knowledge of and experience with pharmacogenetic testingClinical Genetics2012219
39Insights into the pathogenesis of neurofibromatosis 1 vasculopathyClinical Genetics2000216
40Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clinical Genetics1999215
41Mechanisms regulating the development of the corpus callosum and its agenesis in mouse and humanClinical Genetics2004211
42Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern ChinaClinical Genetics2010210
43Liquid biopsy in breast cancer: A comprehensive reviewClinical Genetics2019210
44Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papersClinical Genetics2006209
45Developmental programming of hypothalamic feeding circuitsClinical Genetics2006208
46CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndromeClinical Genetics2009208
47Dyskeratosis congenita: a genetic disorder of many facesClinical Genetics2008206
48MicroRNAs in development and diseaseClinical Genetics2008206
49Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic testClinical Genetics2016205
50The natural history of sclerosteosisClinical Genetics2003199